Unitedhealthcare Pediatric Prior Authorization Policy Linked to Widespread Delays in Critical Medical Care for Children, New Study Reveals
WASHINGTON, D.C. – A comprehensive new study published Tuesday has found that UnitedHealthcare’s pediatric prior authorization process is causing significant delays in care for millions of children across the United States. According to the report, conducted by the National Association of Pediatric Specialists, the health insurance giant’s system for pre-approving medical treatments, medications, and hospital stays has resulted in an average delay of 11.7 business days for urgent procedures. The research analyzed 2.3 million claims filed between January 2022 and March 2025, identifying that approximately 1 in 4 pediatric prior authorization requests were initially denied, often leading to repeated appeals and treatment postponements. Pediatricians and hospital administrators have cited specific cases where children with conditions such as leukemia, epilepsy, and congenital heart defects experienced medically significant setbacks due to withheld authorizations. UnitedHealthcare officials responded to the findings, stating the company is committed to “streamlining the prior authorization process through technological innovation,” and noted a recent 20% reduction in approval wait times for pediatric oncology cases. The study’s authors are now calling for federal regulation of prior authorization protocols, arguing that current state-level oversight is inconsistent. This investigation follows a series of viral social media posts detailing parental accounts of delayed pediatric care under the policy.